Overview

Losartan to Reverse Sickle Nephropathy

Status:
Completed

Trial end date:
2015-12-01

Target enrollment:

Participant gender:

Summary

Sickle cell disease causes kidney damage with increasing age, leading to chronic kidney disease and renal failure in nearly one third of patients with sickle cell disease. Currently, there is no treatment for sickle cell related kidney disease.

Phase:

Phase 2

Details

Lead Sponsor:

Children's Hospital Medical Center, Cincinnati

Treatments:

Losartan